US$ 28.42
bpc 157 fda approval status pipeline clinical trials BPC-157 2026: bpc-157 fda approved status BPC-157
Description
MOTS-c: the mitochondrial peptide for disc cell survival MOTS-c is a 16-amino-acid peptide encoded by the mitochondrial genome that has recently emerged as a promising candidate for intervertebral disc degeneration
For example, mitochondria are home to several core metabolic pathways including the citric acid cycle (tricarboxylic acid cycle, Krebs cycle), oxidative phosphorylation, and the beta-oxidation pathway for fatty acid degradation

See our answer to the question: Which supplements can help with arthritis

Manolopoulos D
